Dr. David Samadi: Noted Urologist

Noted urologist Dr. David Samadi recently shared his thoughts regarding Mitt Romney’s cancer prognosis. Samadi believes that, after treatment for prostate cancer, the outlook is good for Romney.

#prevention #health #healthtips #medicine #highbloodpressure

A post shared by David B Samadi, MD (@drdavidsamadi) on

The former Republican presidential nominee made the announcement that he had undergone prostate surgery last summer to deal with a slow-growing tumor. The tumor had been diagnosed earlier that year. This announcement is one that Samadi takes to be an indication that Romney will likely pursue the Senate seat that is being vacated by Orrin Hatch.

The surgery, which was performed at UC Irvine Hospital by Dr. Thomas Ahlering, was a success. Romney was far from being alone in facing prostate cancer. In 2017, there were 161,360 other men who were also diagnosed with the disease. It is expected that 2018 will bring about 164,690 new cases.

Romney is also typical of those affected by the cancer. Aged 70, he is in the demographic for the disease. Prostate cancer tends to affect men over the age of 65, with approximately 60% of cases being diagnosed in men 65+.

Other well-known men have been among that number, too. John Kerry underwent prostate surgery in 2002 during his presidential run. The following year, former Secretary of State Colin Powell faced the same.

How prostate cancer is treated depends on stage and whether it is localized. The choices facing a man are surgery or radiation. Dr. Samadi generally recommends surgery rather than radiation if the cancer is localized, because studies have shown that patients tend to do better in that situation. Also, radiation may make it more likely that the patient will develop a secondary cancer as a side effect. Plus, survival rates are far better: almost 100% for those with localized cancer who have their prostate removed.

What is important for all men facing a prostate cancer diagnosis is that they have an experienced urologist and/or oncologist. With his M.D. from SUNY Stony Brook School of Medicine and extensive additional education, Dr. Samadi certainly falls into that category. Among the many things that he has done to continue his education since medical school include postgraduate training in urology at at Montefiore Medical Center and in proctology both at Albert Einstein College of Medicine and Montefiore Medical Center. He also completed an oncology fellowship in proctology at Memorial Sloan Kettering Cancer Center and a robotic radical prostatectomy fellowship at Henri Mondor Hospital Creteil.

Learn More: interview.net/dr-david-samadi/